welcome to DuchenneXchange- a positively charged Duchenne muscular dystrophy community.
- join today!
Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life
study id #: NCT01963897
condition: Duchenne Muscular Dystrophy
The study will give a consent based epidemiological overview of Norwegian patients with Duchenne muscular dystrophy younger than 18 years of age. Genotype of the population will be described. Longitudinal development of growth, bone health, and , when applicable, puberty over a two year period will be studied. Questionnaires regarding quality of life will also be an important part of the study.
mechanism of action: No pharmaceutical intervention
last updated: November 22, 2018
start date: August 2013
estimated completion: June 2017
size / enrollment: 73
The participants who are not regularly seen at our regional hospital, are recruited via their local neuropediatrician. Patients who do not come to our region hospital will be seen at their local hospital.Each participant will be seen up to three times with one year between each visit. The visits include clinical examination, DXA scan, x-ray for bone age, and blood tests including several parameters related to bone health, growth and puberty. Standardized questionnaires regarding quality of life (patients and parents) will be used, and certain questions regarding the importance of achieving normal height and puberty will be added. Additional anamnestic data will be retrieved from the patients' medical records.
- Genotype [ Time Frame: 1 day (At first visit) ]
Specific description of mutation
• Diagnosis of Duchenne muscular dystrophy
• Age under 18 years
• Residing in Norway
A safety and efficacy study of ATL1102 in patients with Duchenne muscular dystrophyCurrent DMD therapies are aimed at incre...
Cardiac Involvement in Patients With Duchenne/Becker Muscular DystrophyThis study evaluates the function of the...
The level of agreement between child self-reports and parent proxy-reports of health-related quality of life in boys...Purpose:To investigate the level of agre...
ICER Document Reviews Effectiveness of 3 Duchenne MD TherapiesThe Institute for Clinical and Economic ...
PTC Therapeutics Announces Winners of Global Duchenne Muscular Dystrophy Patient Group STRIVE Awards in Recognition ...PTC Therapeutics, Inc. is pleased to a...
Obesity and endocrine management of the patient with Duchenne muscular dystrophyDuchenne muscular dystrophy (DMD) is ass...
Physical Activity Level of Norwegian Boys With Duchenne Muscular DystrophyThe aim of this population based study i...
Neurology care, diagnostics, and emerging therapies of the patient with Duchenne muscular dystrophyDuchenne muscular dystrophy is the most ...